Catalent Quality Development Leader To Present At China Clinical Trials Outsourcing Congress

QUALITY MANAGEMENT OF GLOBAL CLINICAL TRIALS SUPPLYCatalent Quality Development Leader to Present at China Clinical Trials Outsourcing Congress

Somerset, NJ – March 4, 2013 — Leandra Mollanazar, Vice President, Quality Development and Clinical Services at Catalent Pharma Solutions is to present “Practical Compliance: An Approach to Packaging of Clinical Trials” at the 5th China Clinical Trials Outsourcing Congress in Morristown, NJ, March 4-5, 2013.
The effective planning and management of global clinical trials increasingly requires a thorough understanding of the current landscape, future developments and opportunities presented in performing trials in China. Near-seamless integration of operational, regulatory and logistical challenges is required for trial to be effective, and Ms. Mollanazar’s presentation will illustrate the importance of clinical trial design and project management, the advantages of global networks in ensuring patient adherence, how risk is managed and the benefits of integrating a Quality Management System.
Ms. Mollanazar is an Executive Leader for Catalent’s Development and Clinical Services Business. With more than 20 years of experience in quality assurance, manufacturing, quality control, regulatory affairs and regulatory compliance, Ms. Mollanazar has broad technical expertise in pharmaceutical and medical devices with emphasis in oral dosage, inhalation, injectable liquids and packaging technologies encompassing Research and Development, Clinical and Commercial supply. Ms. Mollanazar has extensive global regulatory compliance experience with the US, European and other regulatory authorities throughout the world.
The congress takes place at the Hyatt Morristown at Headquarters Plaza. For more information please visit

About Catalent

Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products.  With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 9,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and generates more than $1.6 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit

More products. Better treatments. Reliably supplied.™